The objective of this project is to perform a focused and detailed analysis of transcriptional regulation in one chondrocyte-specific gene, Col11a2, in order to identify protein factors that play a role in the activation of this and perhaps other chondrocyte-specific genes. This work will provide information that can be applied to the development of chondrocyte-targeted gene therapy vectors for cartilage disorders such as osteoarthritis. A thorough mutational analysis of the Col11a2 gene has already identified three chondrocyte-specific enhancer elements that are essential for the tissue-specific expression of the gene, and the critical protein-binding sites within each enhancer have been pinpointed. The goal now is to identify the proteins that bind at those critical sites. The work needed to accomplish this goal has been divided into three Specific Aims, as follows: The first Specific Aim is to use the yeast one-hybrid system to identify candidate DNA-binding proteins that may regulate the Col11a2 gene. The second Specific Aim is to use affinity chromatography and mass spectrometry to identify additional candidate DNA-binding proteins. Both approaches will be used because each offers advantages and strengths that complement the limitations of the other approach. The third Specific Aim is to use multiple complementary experiments to test the hypothesis that each one of the identified candidates directly binds the Col11a2 gene and activates expression in vivo. The multiple approaches will include electrophoretic mobility shift assays, transfection-based experiments, in vivo DNA-protein crosslinking, and targeted gene inactivation in mice. This project will result in the identification of multiple proteins that cooperate to achieve chondrocytes-specific expression of the CoI11a2 gene, thus filling a significant gap in our understanding of the mechanisms by which chondrocyte-specific gene expression is regulated. These results will be useful in the development of tissue-targeted gene therapy vectors for the treatment of cartilage disorders. The proteins identified will also become the subjects of future studies on the regulation of other cartilage genes. Finally, the genes for the proteins identified can be examined in future linkage analysis studies to see if they participate in a genetic predisposition to osteoarthritis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR048839-04
Application #
6924689
Study Section
Orthopedics and Musculoskeletal Study Section (ORTH)
Program Officer
Tyree, Bernadette
Project Start
2002-08-01
Project End
2007-07-31
Budget Start
2005-08-01
Budget End
2006-07-31
Support Year
4
Fiscal Year
2005
Total Cost
$163,338
Indirect Cost
Name
Brigham Young University
Department
Physiology
Type
Schools of Arts and Sciences
DUNS #
009094012
City
Provo
State
UT
Country
United States
Zip Code
84602
Cordner, Ryan D; Friend, Lindsey N; Mayo, Jaime L et al. (2017) The BMP2 nuclear variant, nBMP2, is expressed in mouse hippocampus and impacts memory. Sci Rep 7:46464
Bridgewater, Laura C; Mayo, Jaime L; Evanson, Bradley G et al. (2013) A novel bone morphogenetic protein 2 mutant mouse, nBmp2NLS(tm), displays impaired intracellular Ca2+ handling in skeletal muscle. Biomed Res Int 2013:125492
Holt, D W; Henderson, M L; Stockdale, C E et al. (2012) Osteoarthritis-like changes in the heterozygous sedc mouse associated with the HtrA1-Ddr2-Mmp-13 degradative pathway: a new model of osteoarthritis. Osteoarthritis Cartilage 20:430-9
Felin, Jenny E; Mayo, Jaime L; Loos, Trina J et al. (2010) Nuclear variants of bone morphogenetic proteins. BMC Cell Biol 11:20
Müller, Patrick; Crofts, Justin D; Newman, Ben S et al. (2010) SOX9 mediates the retinoic acid-induced HES-1 gene expression in human breast cancer cells. Breast Cancer Res Treat 120:317-26
Mayo, Jaime L; Holden, Devin N; Barrow, Jeffery R et al. (2009) The transcription factor Lc-Maf participates in Col27a1 regulation during chondrocyte maturation. Exp Cell Res 315:2293-300
Seegmiller, Robert E; Bomsta, Brandon D; Bridgewater, Laura C et al. (2008) The heterozygous disproportionate micromelia (dmm) mouse: morphological changes in fetal cartilage precede postnatal dwarfism and compared with lethal homozygotes can explain the mild phenotype. J Histochem Cytochem 56:1003-11
Genzer, Mary Ann; Bridgewater, Laura C (2007) A Col9a1 enhancer element activated by two interdependent SOX9 dimers. Nucleic Acids Res 35:1178-86
Bomsta, B D; Bridgewater, L C; Seegmiller, R E (2006) Premature osteoarthritis in the Disproportionate micromelia (Dmm) mouse. Osteoarthritis Cartilage 14:477-85
Jenkins, Elizabeth; Moss, Jennie B; Pace, James M et al. (2005) The new collagen gene COL27A1 contains SOX9-responsive enhancer elements. Matrix Biol 24:177-84

Showing the most recent 10 out of 12 publications